Maurice Flemming, PA
Medical · Kansas City, MONPI 1063540177
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.3% — the pattern of someone who eats at a lot of different presentations.
Across 69 payments — averaging $37.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$477
- AstraZeneca$426
- Teva Pharmaceuticals USA, Inc.$363
- Novo Nordisk$309
- GSK$227
- Amgen$122
- plus $679 from 15 others
What the payments were for
- Food & beverage$2,604100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 13 | $477 |
| AstraZeneca | 10 | $426 |
| Teva Pharmaceuticals USA, Inc. | 4 | $363 |
| Novo Nordisk | 10 | $309 |
| GSK | 2 | $227 |
| Amgen | 1 | $122 |
| Exact Sciences | 1 | $120 |
| Protega Pharmaceutials Inc | 6 | $97 |
| Pfizer | 4 | $73 |
| Viiv Healthcare Company | 1 | $60 |
| Lilly USA, LLC | 3 | $55 |
| UCB, Inc. | 2 | $50 |
| Dexcom, Inc. | 2 | $50 |
| Sanofi Pasteur Inc. | 2 | $42 |
| Ironwood Pharmaceuticals, Inc | 2 | $27 |
| Gilead | 1 | $26 |
| Insulet Corporation | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Phadia US Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FreeStyle Libre 2$301
- FARXIGA$250
- AREXVY$227
- FREESTYLE LIBRE 3$141
- Repatha$122
- The Cologuard Plus Collection Kit$120
- AUSTEDO$119
- RYBELSUS$104
- Austedo XR$101
How this compares
$2,604 in reported general payments places this provider in the 75th percentile of 198 medical providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 117 | $152,842 |
| JanuviaSitagliptin Phosphate | 94 | $106,010 |
| OzempicSemaglutide | 95 | $96,244 |
| JanumetSitagliptin Phos/Metformin Hcl | 90 | $93,791 |
| EliquisApixaban | 42 | $47,910 |
| TrulicityDulaglutide | 38 | $44,894 |
| LinzessLinaclotide | 43 | $41,357 |
| XareltoRivaroxaban | 25 | $27,539 |
| Spiriva HandihalerTiotropium Bromide | 33 | $27,012 |
| FarxigaDapagliflozin Propanediol | 15 | $23,891 |
| SymbicortBudesonide/Formoterol Fumarate | 63 | $21,598 |
| MounjaroTirzepatide | 12 | $15,100 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 18 | $14,647 |
| Spiriva RespimatTiotropium Bromide | 18 | $12,497 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 60 | $11,208 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Janumet, Janumet Xr | $15 | $214,449202 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $14 | $165,340135 claims |
| Novo NordiskOzempic | $309 | $96,24495 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $55 | $59,99450 claims |
| PfizerEliquis, Dilantin | $73 | $50,33953 claims |
| AstraZenecaFarxiga, Symbicort | $426 | $45,48978 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $227 | $23,97840 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 198 medical providers in Missouri.
Other medical in Kansas City
- Vanessa JohnsonKansas City$10K
- Dylan ToyneKansas City$4K
- Karen LeuenbergerKansas City$2K
- Brenna CarlsonKansas City$2K
- Melanie ChisamSpringfield$92K
- Emily JensenBowling Green$51K
- Sarah WilmsmeyerChesterfield$22K
- Amy MosmanSaint Louis$21K
- Dustin BartlettSpringfield$21K
- Alexa Fider-WhyteSaint Louis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.